INJECTA™ - BIOAVAILABILITY ENHANCEMENT FOR INJECTABLES

ABITEC introduces new INJECTA^™ parenteral grade lipid excipients to enable improved solubilization and permeation for injectable APIs. The INJECTA grade portfolio of products include: Captex^® medium chain triglycerides and Capmul^® mono-and di-glycerides of glycol esters fully analyzed and packaged for parenteral application.
 

INJECTA products provide improved solubility for BCS II and IV NCEs, aid in controlled release and go through processing in state-of-the-art facilities to ensure products of the highest quality. ABITEC purified lipid excipients meet applicable quality standards and comply with current and proposed monographs.
 

Please visit ABITEC at CPHI Worldwide in Barcelona at Stand # 4D56 to learn more about the INJECTA product line and request a sample. You may also download our brochure for more information at http://www.abiteccorp.com/right-on-target.
 

Contact details:
ABITEC CORPORATION
Website: www.abiteccorp.com
E-mail: acoulter@abiteccorp.com